Purpose: Based on autopsy findings and toxicological results, it was ascertained whether chronic fetal exposure to methadone (MTD) could have caused intrauterine death of a fetus born to a mother under MTD maintenance therapy. Methods: Complete fetal autopsy, placental examination and toxicological and histological analyses were performed on a 39-week-old stillborn fetus, whose mother had regularly taken MTD during the pregnancy. The MTD and its main metabolite 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) were quantified in fetal tissues (brain, liver and kidney) by ultra-high-performance liquid chromatography–tandem mass spectrometry. A fully validated toxicological analytical method was developed. Results: High levels of MTD and EDDP were present in all samples. The EDDP-to-MTD ratios were similar in the liver and kidney, but in the brain, MTD was predominant. Placental histology showed a thrombotic partially organised lesion in the first branches of the umbilical vein (chorionic venous vessels) and delayed villous maturation (DVM) diffusely found in the parenchyma. Conclusions: High levels of MTD and EDDP correlated with chronic fetal exposure to MTD maintenance therapy in pregnancy. Placenta DVM can be associated with the MTD exposure, indirectly affecting glycaemic balance. Fetal cause of death seemed to be related to a global hypoxic-ischemic status as a combination of chronic fetal MTD intoxication, placental DVM and impaired placenta blood flow due to chorionic thrombosis.
- Human fetus
ASJC Scopus subject areas
- Pathology and Forensic Medicine
- Biochemistry, medical